Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 9476Neoplasms 6587Prostatic Neoplasms 4399Colorectal Neoplasms 3977Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Pancreatic Neoplasms 2478Carcinoma, Hepatocellular 2411Leukemia, Myeloid, Acute 2265Multiple Myeloma 2120Stomach Neoplasms 2108Neoplasm Metastasis 1911Head and Neck Neoplasms 1869Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1729Brain Neoplasms 1699Rectal Neoplasms 1676Melanoma 1654Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1485Esophageal Neoplasms 1311Glioblastoma 1307Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Tamoxifen 2palbociclib 1exemestane 1elacestrant 1Letrozole 1Fulvestrant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × ER+ Breast Cancer × Clear all
NCT06923527 2026-05-12

Circulating Tumor DNA

Yale University

Phase 2 Recruiting
50 enrolled
Breast

ER+ Breast Cancer

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting
1,100 enrolled
Breast

ER+ Breast Cancer

NCT04824014 2024-02-06

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Phase 2 Unknown
150 enrolled
Breast

ER+ Breast Cancer

NCT05525481 2023-11-01

PREDICTAM

Erasmus Medical Center

Phase 4 Unknown
100 enrolled
Breast

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡